Quick highlights
- Key clotting protein measurement used in coagulation evaluation
- Interpreted with PT/INR, aPTT, platelets, and D-dimer for full picture
- Can change in inflammation, pregnancy, and acute illness—context matters
- No fasting; citrate plasma sample
- Important in clinician-led bleeding/clotting disorder workups
- Used in selected hospital protocols (e.g., DIC assessment) under supervision
- Anticoagulants influence interpretation—disclose use and timing
- Home blood collection available in many service areas
- Clear guidance against self-adjusting blood thinners
- SEO coverage: fibrinogen test, coagulation test fibrinogen, clotting protein blood test
What’s included
Preparation
- Book blood draw (home or lab)
- No fasting required
- Disclose anticoagulants and last dose timing
- Inform clinician about recent surgery, pregnancy, infections, or liver disease
- Collect citrate plasma sample via trained phlebotomist
- Download report from <a href='/my-account/'>View reports</a>
- Review with clinician alongside coagulation profile
- Seek urgent care for active bleeding or clot symptoms
FAQs
A blood clotting protein produced by the liver that helps form clots.
No.
To support evaluation of bleeding/clotting disorders and certain clinical pathways.
Yes; it can rise with inflammation, infection, pregnancy, and other conditions—clinicians interpret contextually.
Yes; it may occur in severe liver disease, consumption in DIC, or rare disorders—clinician evaluation is essential.
Citrate plasma.
Often same day or within 24 hours.
Yes in many serviceable areas.
They can affect coagulation interpretation; disclose medicines and dosing schedule.
PT/INR, aPTT, platelet count, D-dimer, CBC.
No; DIC assessment uses multiple labs and clinical findings.
Uncontrolled bleeding, chest pain, breathlessness, or one-leg swelling requires urgent evaluation.
Download from <a href='/my-account/'>View reports</a>.
No; decisions are clinician-led.
Notes
Fibrinogen levels vary with inflammation.
